VERNON W ANTHONY 4
4 · NovoCure Ltd · Filed Jun 6, 2024
Insider Transaction Report
Form 4
NovoCure LtdNVCR
VERNON W ANTHONY
Director
Transactions
- Award
Restricted Stock Units
2024-06-05+4,053→ 169,850 total - Sale
Ordinary Shares
2024-06-04$23.89/sh−964$23,033→ 164,833 total - Award
Stock Option (Right to Buy)
2024-06-05+6,229→ 6,229 totalExercise: $23.13Exp: 2034-06-04→ Ordinary Shares (6,229 underlying)
Footnotes (3)
- [F1]This transaction was executed in multiple trades at prices ranging from $23.78 USD to $24.00 USD; the price reported above reflects the weighted average sale price.
- [F2]These restricted stock units are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2025 annual general meeting of shareholders.
- [F3]Options to buy 6,229 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2025 annual general meeting of shareholders.